Larvol Cliniclarvol.hashnode.dev·Jul 18, 2024TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II TrialAbstract In this randomized phase II clinical trial, we evaluated the effectiveness of adding the TLR agonists, poly-ICLC or resiquimod, to autologous tumor lysate-pulsed dendritic cell (ATL-DC) vaccination in patients with newly-diagnosed or recurre...indiaAdd a thoughtful commentNo comments yetBe the first to start the conversation.